Octapharma Octapharma AB Octapharma GmbH Octapharma Pharmazeutika Produktionsges.m.b.H.

The medicinal product is used for replacement therapy in individuals with congenital or acquired antibody deficiency and in individuals exposed to measles (in situations where vaccination is contraindicated). It may also be used in the treatment of selected autoimmune disorders, such as immune thrombocytopenia (ITP), Kawasaki disease, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), and multifocal motor neuropathy (MMN).

Dosage form: solution for infusion

ATC: J06BA02